Bio-Techne Cp Cmn (TECH) 106.88 $TECH Bio-Techne

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bio-Techne Cp Cmn (TECH) 106.88 $TECH

Bio-Techne Announces Investor Day And Webcast
PR Newswire - Wed Aug 31, 8:35AM CDT
Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host its 2016 Investor Day on Thursday, September 15, 2016, starting at 9:00 a.m. EST. The meeting will take place at the Lotte New York Palace Hotel, 455 Madison Avenue, New York City.
TECH: 106.88 (+0.35)

RSI Alert: Bio-Techne (TECH) Now Oversold
MarketNewsVideo.com - Wed Aug 24, 3:32PM CDT
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative...
TECH: 106.88 (+0.35)

Bio-Techne Declares Dividend
PR Newswire - Wed Aug 17, 6:00AM CDT
Bio-Techne Corporation (NASDAQ:TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended June 30, 2016. The quarterly dividend will be payable September 12, 2016 to all common shareholders of record on August 29, 2016. Future cash dividends will be considered by the Board of Directors on a quarterly basis.
TECH: 106.88 (+0.35)

Medical Stocks' Earnings to Watch Next Week: TECH, WVE, EARS
Zacks Equity Research - Zacks Investment Research - Fri Aug 12, 8:21AM CDT
How will medical stocks Bio-Techne, WAVE Life Sciences, and Auris perform this earnings season?
WVE: 24.99 (+1.71), EARS: 1.71 (unch), TECH: 106.88 (+0.35)

Uptrend Call Working As Techne Stock Rises 26.8% (TECH)
Comtex SmarTrend(R) - Tue Aug 09, 1:29PM CDT
SmarTrend identified an Uptrend for Techne (NASDAQ:TECH) on February 2nd, 2016 at $87.91. In approximately 6 months, Techne has returned 26.82% as of today's recent price of $111.49.
TECH: 106.88 (+0.35)

Bio-Techne To Host Conference Call On August 17, 2016 To Announce Fourth Quarter Financial Results
PR Newswire - Wed Aug 03, 6:00AM CDT
Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Wednesday, August 17, 2016, at 8:00 a.m. CDT to review fourth quarter fiscal 2016 financial results.
TECH: 106.88 (+0.35)

ACADIA (ACAD) Q2 Earnings: What's in Store for the Stock?
Arpita Dutt - Zacks Investment Research - Tue Aug 02, 6:54AM CDT
Investor focus will remain on the performance of ACADIA's (ACAD) recently launched Nuplazid.
ACAD: 31.59 (-0.51), RPTP: 7.28 (+0.04), TECH: 106.88 (+0.35), XLRN: 30.84 (+0.59)

Ligand (LGND) Q2 Earnings: What's in Store for the Stock?
Arpita Dutt - Zacks Investment Research - Tue Aug 02, 6:18AM CDT
Our proven model does not conclusively show that Ligand (LGND) is likely to beat earnings estimates this quarter.
RPTP: 7.28 (+0.04), TECH: 106.88 (+0.35), LGND: 106.19 (-0.85), XLRN: 30.84 (+0.59)

Teva (TEVA): Stock Likely to Beat on Earnings in Q2 Again?
Arpita Dutt - Zacks Investment Research - Tue Aug 02, 6:06AM CDT
Our proven model shows that Teva (TEVA) is likely to beat earnings this quarter because it has the right combination of two key ingredients.
AGN: 235.96 (-1.80), RPTP: 7.28 (+0.04), TECH: 106.88 (+0.35), TEVA: 51.22 (+0.32)

Juno (JUNO) Q2 Earnings: Will the Stock Disappoint?
Arpita Dutt - Zacks Investment Research - Tue Aug 02, 5:49AM CDT
With no approved products in its portfolio, focus will remain on Juno's (JUNO) pipeline and cash burn.
RPTP: 7.28 (+0.04), TECH: 106.88 (+0.35), JUNO: 28.44 (-0.85), CELG: 105.49 (-0.88)

Techne Has Returned 29.4% Since SmarTrend Recommendation (TECH)
Comtex SmarTrend(R) - Tue Aug 02, 12:56AM CDT
SmarTrend identified an Uptrend for Techne (NASDAQ:TECH) on February 2nd, 2016 at $87.91. In approximately 6 months, Techne has returned 29.43% as of today's recent price of $113.78.
TECH: 106.88 (+0.35)

Bio-Techne Corporation Completed its Acquisition of Advanced Cell Diagnostics
PR Newswire - Mon Aug 01, 4:27PM CDT
Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed its acquisition of Advanced Cell Diagnostics of Newark, CA. This represents the 9th acquisition for Bio-Techne in the last three years. With these acquisitions, Minneapolis-based Bio-Techne has grown from approximately 650 employees in 2013 to nearly 1,700 staff worldwide and has expanded its global reach with subsidiaries in every major geographic market. Organically, we continue to develop and launch in excess of 1,500 new products to market on a yearly basis which enable researchers to address new and more complex questions in the life science field. This latest acquisition of ACD is consistent with our strategic plan, which includes both organic growth and acquisitions that fill portfolio gaps.
TECH: 106.88 (+0.35)

Techne Up 28.4% Since SmarTrend Uptrend Call (TECH)
Comtex SmarTrend(R) - Wed Jun 08, 1:04AM CDT
SmarTrend identified an Uptrend for Techne (NASDAQ:TECH) on February 2nd, 2016 at $87.91. In approximately 4 months, Techne has returned 28.45% as of today's recent price of $112.92.
TECH: 106.88 (+0.35)

Watch for Techne to Potentially Pullback After Gaining 2.36% Yesterday
Comtex SmarTrend(R) - Fri May 27, 3:18PM CDT
Techne (NASDAQ:TECH) traded in a range yesterday that spanned from a low of $106.43 to a high of $109.93. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $108.18 on volume of 111,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TECH: 106.88 (+0.35)

Techne Shares Up 19.6% Since SmarTrend's Buy Recommendation (TECH)
Comtex SmarTrend(R) - Tue May 24, 1:28AM CDT
SmarTrend identified an Uptrend for Techne (NASDAQ:TECH) on February 2nd, 2016 at $87.91. In approximately 4 months, Techne has returned 19.55% as of today's recent price of $105.10.
TECH: 106.88 (+0.35)

TrovaGene (TROV) Q1 Loss Wider than Expected, Stock Gains
Zacks Equity Research - Zacks Investment Research - Wed May 11, 7:16AM CDT
TrovaGene Inc (TROV) reported adjusted loss of 36 cents per share in the first quarter of 2016, wider than the year-ago loss of 33 cents.
TROV: 4.96 (unch), TECH: 106.88 (+0.35), EXAC: 27.90 (+0.10), NVRO: 95.91 (-0.11)

Bio-Techne (TECH): Moving Average Crossover Alert
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:38AM CDT
Are you a technical investor? If so, it may be time to consider Bio-Techne Corp. (TECH) for your portfolio
TECH: 106.88 (+0.35)

Bio-Techne Corporation Acquires Access to B-MoGen Biotechnologies' Gene Editing Technology
PR Newswire - Wed May 04, 5:00AM CDT
Bio-Techne Corporation (NASDAQ: TECH) and B-MoGen Biotechnologies, Inc. announced today that Bio-Techne has made a seed investment in B-MoGen and the parties have entered into collaboration agreement which gives Bio-Techne access to gene editing technology.
TECH: 106.88 (+0.35)

Upgrade Alert for Techne (TECH)
Comtex SmarTrend(R) - Wed May 04, 3:13AM CDT
Techne (NASDAQ:TECH) was upgraded from Neutral to Buy at Janney Montgomery today. The stock closed yesterday at $100.55 on volume of 595,000 shares, above average daily volume of 231,000. Techne Corporation, through Research and Diagnostic Systems, Inc., manufactures biological products. The Company also, through R&D Systems Europe, Ltd., distributes biotechnology products.
TECH: 106.88 (+0.35)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 61

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Dallas College Recognition Signals Workforce Value

Updated Category News Views 49

Economic mobility rarely arrives with brass bands, but it can show up in a community-college ranking. Dallas College has landed on TIME and Statista's inaugural America’s Best Community Colleges 2027 list, one of 250 schools selected from roughly 1,100 nationwide. For a region that keeps talking about talent pipelines, this is a useful piece of outside validation—not...

Continue Reading
Align Wagner Collection Tests Men's Footwear Depth

Updated Category News Views 57

Three pairs of shoes are not a revolution, but they can expose whether a young brand has its footing. Align, established in 2025 by H.H. Brown, is rolling out the Wagner collection for Fall-Winter 2026 with a waterproof boot, a penny loafer and a lace-up oxford. That is a sensible little arsenal, not some overstuffed catalog dreamed up by a marketing committee that has...

Continue Reading
Lennar's 6.73% Slide Puts Disclosure Claims in Focus

Updated Category News Views 12

A homebuilder can survive ugly margins; murky demand signals are another beast entirely. Lennar is staring at a securities class action after a bruising run of disclosures and market reactions, and the central issue is not whether housing got tougher. Everybody with a pulse knew rates were squeezing buyers. The issue is whether NYSE:LEN gave investors a sufficiently clear...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Duetti, CesiumAstro, and a Busy NYSE Capital Morning

Updated Category News Views 78

Three very different piles of money are jamming up the November 20 NYSE slate, and that contrast is the whole point. Private music catalogs, space-and-defense communications, and a new stock-and-bond ETF do not belong in the same bucket. Yet all three are competing for investor attention before the opening bell, alongside Danaos Corporation's 20th listing anniversary....

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 80

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
Nansha's Trade Pitch Has Numbers, but Questions Remain

Updated Category News Views 84

A Chilean cherry spending 22 days at sea can tell an investor plenty about where Guangzhou's Nansha District wants to sit in Asia-Pacific commerce. Not glamorous, no. But trade infrastructure rarely is until volumes pile up, routes deepen, and somebody else finds they cannot easily replicate the network. Nansha is using the expected 33rd APEC Economic Leaders' Meeting in...

Continue Reading
Mason Adds Nonprofit Expertise to Institutional Bench

Updated Category News Views 110

Endowment committees rarely need more noise; they need somebody who has actually sat through the uncomfortable votes. Mason Investment Advisory Services has hired Rebecca “Becky” Farnsworth, CFA, as a senior investment consultant, and this looks like a practical addition rather than the usual chest-thumping personnel announcement. Her stated focus will be...

Continue Reading
Oatly’s $4.13 Tender Offer Is a Legal Detour, Not a Sale

Updated Category News Views 100

A $4.13 cash offer trading against a $7.17 close is the sort of thing that makes investors squint hard, and Verlinvest is practically waving a flag telling them why. This is not a conventional attempt to buy Oatly Group AB. It is a technical tender offer built to satisfy Swedish takeover rules while Verlinvest buys out its joint-venture partner’s interest in Oatly’s...

Continue Reading

Top 5 Most Recently Viewed Articles

DatChat Receives Mexican Patent for Enhanced Privacy Solutions

Updated Category News Views 157

DatChat's Latest Patent Achievement New Brunswick, NJ - DatChat, Inc. (NASDAQ: DATS), a leading company in secure messaging and social media, has exciting news to share. Recently, the Mexican Patent office issued a Notice of Allowance for DatChat's patent application titled "Systems and Methods of Transforming Electronic Content." This development follows the company...

Continue Reading
Flora Growth Partners with Canopy to Enhance Cannabis Access

Updated Category News Views 111

Flora Growth Enters the Australian Medical Cannabis Market Flora Growth Corp (NASDAQ: FLGC) has recently taken a significant step into the Australian medical cannabis arena through its strategic partnership with Canopy Growth Corp (NASDAQ: CGC). A distribution agreement has been signed, allowing Flora's subsidiary, Australian Vaporizers, to handle the distribution of...

Continue Reading
Digital Brands Group Sets Public Offering of 11.36 Million Units

Updated Category News Views 167

Digital Brands Group Projects Strong Growth with New Offering Digital Brands Group, Inc. (OTC PINK: DBGI), a unique entity known for curating luxury lifestyle brands, has recently made headlines with their announcement regarding a public offering. This initiative, which involves an impressive volume of 11.36 million units, is set to make waves in the market. Details of...

Continue Reading
Unraveling Solana's Remarkable Rise From $11 to $166

Updated Category News Views 154

Unraveling Solana's Remarkable Rise From $11 to $166 Solana (SOL), a cryptocurrency that emerged in March 2020, has astonished investors with its dramatic increase in value. It has risen more than 15 times its initial value, predominantly bolstered by a vibrant ecosystem that has flourished around various meme coins. Jim Cramer’s Warning In 2022, Jim Cramer, a prominent...

Continue Reading
LO3 Capital Revolutionizes Travel Services with CCRA Deal

Updated Category News Views 189

LO3 Capital Makes Strategic Investment in CCRA International LO3 Capital, a dynamic private investment firm, is making waves with its recent senior debt investment in CCRA International, Inc. This relationship is pivotal for CCRA, a technology-driven travel services platform, as it progresses towards acquiring ABC Global Services. This acquisition is set to form one of...

Continue Reading